CORD Files for Premarket Approval with the U.S. Food and Drug Administration for the SC9 Intraocular Lens for Cataract Surgery

SC9 Incorporates 21 Patented Features Designed to Position the Lens for Superior Intermediate Vision ALISO VIEJO, Calif., Dec. 8, 2022 /PRNewswire/ -- CORD, LLC, a privately held ophthalmic medical device company, announced today that it has submitted a Premarket Approval (PMA)...

Click to view original post